Supernus Pharmaceuticals

SUPN

SUPN
Supernus Pharmaceuticals Stock Quote
$22.35 -$0.13 -0.6%
Price as of September 18, 2020, 4:30 p.m. EDT View Interactive SUPN Charts

Supernus Pharmaceuticals Inc specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system or CNS diseases.

Interactive Chart


News & Analysis: Supernus Pharmaceuticals

All

Market Moves

Earnings
GettyImages-471816633

3 Top Value Stocks to Buy in May

Neha Chamaria, Rich Duprey, and George Budwell | May 8, 2019

Deep-value stocks like Supernus Pharmaceuticals and Party City look attractive now.

Key Data Points

Primary metrics and data points about Supernus Pharmaceuticals.
Current Price: $22.35
Prev Close: $22.35
Open: $22.67
Bid: $22.32
Ask: $22.35
Day's Range: $22.15 - $22.70
52wk Range: $13.12 - $29.36
Volume: 584,177
Avg Vol 465,010
Market Cap: $1B
P/E (ttm): 9.93

Company Rating

What our community thinks about Supernus Pharmaceuticals
CAPS Rating 4 out of 5
 
60 Outperform
11 Underperform
CAPS All Stars
 
10 Outperform
2 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company
Jack A. Khattar, CEO

Jack A. Khattar, CEO

93% Approve

Based on 18 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Supernus Pharmaceuticals.

Supernus Pharmaceuticals Inc specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system or CNS diseases.

  • Exchange: NASDAQ
  • Sector: Health Care
  • Industry: Pharmaceuticals